Pulmonx (LUNG) Stock Highlights

7.36 | -4.54%

2024-11-08 05:14:22

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the companys solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets.

Statistics

Range Today

7.21 7.68

Volume Today 179K

Range 1 Year

5.46 14.84

Volume 1 Year 96.15M

Range 3 Year

4.07 45.49

Volume 3 Year 302.44M

Range 10 Year

4.07 69.48

Volume 10 Year 398.15M

Highlights

Market Capitalization 245.49M (small)

Floating Shares 37.6M

Current Price 7.36

Price To Earnings -4.3

Price To Revenue 2.45

Price To Book 2.62

Earnings Per Share -1.47

Payout Ratio 0%

Performance

Latest -4.54%

1 Month +1.8%

3 Months +22.46%

6 Months -20.78%

1 Year -23.57%

3 Years -83.66%

5 Years -81.6%

10 Years -81.6%

Benchmarks

Market Capitalization

55 / 92

Gross Profits

56 / 85

Total Revenue

60 / 89

Total Rank

74 / 92

Free Cashflow

65 / 90

Performance 5 years

74 / 92

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.